NCT05029011View on ClinicalTrials.gov

Low-cost Sensor System for COVID-19 Patient Monitoring: Validation of BRAEBON Vital Signs Monitor (VTS)

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

February 7, 2022

Primary Completion Date

July 15, 2022

Study Completion Date

July 15, 2022

Conditions
COVID-19
Interventions
DEVICE

BRAEBON VTS

The BRAEBON VTS is a portable device that continuously monitors vital signs. Participants in the study will wear the BRAEBON VTS for 24 hours.

Trial Locations (1)

K7L 2V7

Kingston Health Sciences Centre, Kingston

Sponsors
All Listed Sponsors
collaborator

Braebon Medical Corporation

UNKNOWN

collaborator

National Research Council, Canada

UNKNOWN

lead

Helen S. Driver, PhD

OTHER